-
CCK-8 Suppresses IgG1 in Activated B Cells
2026-10-01
The reference study shows that sulfated cholecystokinin octapeptide suppresses proliferation, IgG1 transcription, and IgG1 production in lipopolysaccharide-activated mouse B cells. Its receptor-antagonist experiments identify CCK2R signaling as the principal pathway and connect the response to time-dependent regulation of Blimp1, Pax5, Xbp1, and Bcl6.
-
Trizol RNA Extraction in Ferroptosis Research
2026-09-30
Total RNA Extraction Reagent (Trizol) can support molecular analysis of ferroptosis, DHODH regulation, and macrophage responses after carbon-ion radiotherapy. This guide connects extraction chemistry with assay design, controls, and interpretation of the latest gastric cancer findings.
-
Clodronate Liposomes: Reliable Macrophage Depletion
2026-09-30
Learn how Clodronate Liposomes (SKU K2721) can clarify macrophage contributions to viability, proliferation, cytotoxicity, and phagocytosis assays. This scenario-based guide covers experimental design, route selection, controls, interpretation, storage, and practical vendor evaluation.
-
Mifepristone (RU486): A Mechanism-First Framework
2026-09-29
Mifepristone and RU486 are best understood as receptor-perturbation tools, not simply cytotoxic reagents. This mechanism-first guide connects progesterone-receptor biology, tissue-specific nuclear-receptor regulation, cancer phenotyping, and reproductive assays while translating lessons from a hippocampal CYP study into better experimental controls.
-
KR-12 Antimicrobial Peptides: Design and Applications
2026-09-29
The 2024 review of KR-12 explains how a compact fragment of human LL-37 has become a versatile platform for antimicrobial peptide engineering. It connects sequence modification, structural stabilization, nanoformulation, and biomaterial immobilization with potential activity against resistant pathogens, biofilms, endotoxins, and dysregulated inflammation.
-
Anti-HMGB1 Rabbit Monoclonal Antibody: MA3057
2026-09-28
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is a research-use reagent, not a diagnostic or therapeutic product; assay-specific working conditions should be established locally because no directly matched paper-specific validation is supplied here.
-
Methicillin Sodium Salt in Assay Workflows
2026-09-27
A scenario-driven guide to using Methicillin sodium salt (SKU C3238) in MSSA susceptibility and infection-model workflows without confusing bacterial effects with mammalian cell viability. It covers mechanism, compatibility, practical handling, MIC interpretation, and evidence-based product selection.
-
Vancomycin hydrochloride assay workflows
2026-09-26
Build reproducible Gram-positive susceptibility and resistance studies around vancomycin hydrochloride, with practical preparation, assay, and troubleshooting guidance. A ceftolozane-tazobactam review offers useful lessons in resistance-study design—but its findings are not direct evidence about vancomycin activity.
-
Resiniferatoxin (RTX) in TRPV1 Assays
2026-09-26
Use Resiniferatoxin (RTX) to probe TRPV1 calcium signaling, sensory-neuron desensitization, and pain behaviors—with assay design informed by new evidence that membrane cholesterol can tune agonist-evoked nociception. This guide connects practical RTX workflows to controls, readouts, and troubleshooting without treating exploratory settings as validated dosing instructions.
-
VPS13A–XKR1 Structure Reveals Lipid Delivery Mechanism
2026-09-25
Near-atomic cryo-EM and molecular dynamics analyses describe how VPS13A engages the plasma-membrane scramblase XKR1 to deliver lipids to the cytosolic leaflet, where scrambling can support membrane expansion. The study offers a structural model for cooperation between a bridge-like lipid-transfer protein and a scramblase, while leaving important questions about how broadly the mechanism applies to other VPS13 proteins.
-
WAY-100635 in 5-HT1A Pain-Circuit Assays
2026-09-25
Use WAY-100635 to test whether 5-HT1A receptor signaling contributes to sensory or affective outcomes in pain models—not to assume that serotonergic activity alone identifies the receptor involved. This guide connects a recent cannabidiol pain study to practical antagonist, binding, and functional-assay workflows, with troubleshooting steps for interpretable results.
-
COX-2 Timing in Venom-Induced Muscle Revascularization
2026-09-24
A mouse model of Bothrops asper venom injury reveals that COX-2 has a time-dependent role: its activity helps limit early muscle ischemia, while early inhibition is associated with stronger later angiogenic and matrix-remodeling signals. The findings distinguish immediate vascular protection from subsequent revascularization and caution against interpreting angiogenic markers alone as evidence of restored blood flow.
-
Gastrin I (human): Reliable Assay Design
2026-09-24
Practical guidance for selecting, preparing, and interpreting Gastrin I (human) in gastric acid secretion and cell-based studies. This scenario-driven guide explains what SKU B5358 supports, how to handle its formulation, and where intestinal organoid evidence should—and should not—be applied.
-
CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer
2026-09-23
The reference study identifies a paracrine mechanism by which cancer-associated fibroblasts promote mitochondrial biogenesis, oxidative phosphorylation, and chemotherapy resistance in prostate cancer. Its findings connect CAF-derived ANGPTL4 to membrane-associated IQGAP1 and downstream Raf–MEK–ERK–PGC1α signaling, while also supporting IQGAP1-directed intervention as a potential strategy for improving docetaxel responsiveness.
-
Phosphorylation as a Translational Control Point
2026-09-23
Phosphorylation-dependent mobility shifts can connect mechanistic biology with practical assay development. Using the CaMKIIδ–BMAL1 findings from an ISX-9 circadian study as a case study, this article explains how Phosbind Acrylamide can support antibody-free protein phosphorylation analysis, where it complements immunoblotting and mass spectrometry, and how translational teams can interpret the resulting evidence without overstating what a gel shift proves.